Comparative bioavailability study of two brands of prazosin-containing tablets in healthy volunteers. 1990

P J Guelen, and T J Janssen, and M H Lam, and T B Vree, and P S Exler
Farma Research BV, Ravenstein, The Netherlands.

The bioavailability of two prazosin formulations was studied in 12 healthy volunteers. 1 Subject left the study. Based on the statistical tests of the pharmacokinetic parameters of prazosin in 11 volunteers, such as t 1/2, Cmax, tmax and AUC, it could be concluded that both preparations had comparable bioavailabilities.

UI MeSH Term Description Entries
D008297 Male Males
D011224 Prazosin A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION. Furazosin,Minipress,Pratsiol,Prazosin HCL,Prazosin Hydrochloride,HCL, Prazosin,Hydrochloride, Prazosin
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013607 Tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed) Tablet

Related Publications

P J Guelen, and T J Janssen, and M H Lam, and T B Vree, and P S Exler
June 2009, International journal of clinical pharmacology and therapeutics,
P J Guelen, and T J Janssen, and M H Lam, and T B Vree, and P S Exler
January 2005, Biopharmaceutics & drug disposition,
P J Guelen, and T J Janssen, and M H Lam, and T B Vree, and P S Exler
January 2009, Arzneimittel-Forschung,
P J Guelen, and T J Janssen, and M H Lam, and T B Vree, and P S Exler
October 1988, The Journal of the Association of Physicians of India,
P J Guelen, and T J Janssen, and M H Lam, and T B Vree, and P S Exler
January 1998, European journal of drug metabolism and pharmacokinetics,
P J Guelen, and T J Janssen, and M H Lam, and T B Vree, and P S Exler
January 2007, Arzneimittel-Forschung,
P J Guelen, and T J Janssen, and M H Lam, and T B Vree, and P S Exler
July 2003, International journal of clinical pharmacology and therapeutics,
P J Guelen, and T J Janssen, and M H Lam, and T B Vree, and P S Exler
January 2002, European journal of drug metabolism and pharmacokinetics,
P J Guelen, and T J Janssen, and M H Lam, and T B Vree, and P S Exler
September 2002, The Journal of the Association of Physicians of India,
P J Guelen, and T J Janssen, and M H Lam, and T B Vree, and P S Exler
January 2010, Arzneimittel-Forschung,
Copied contents to your clipboard!